The Journal of Clinical Pharmacology · 1982 · 39 citations · 4 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsCardiac MedicationsCardiac PharmacotherapyCardiovascular PharmacologyDiltiazem TherapyEquilibrium DialysisIndividual Therapeutic RangePharmacokinetics Of Cardiovascular DrugsSerum Protein BindingTherapeutic Dose Range
Diltiazem binding was measured by equilibrium dialysis in the serum of five healthy male subjects, aged 22 to 34 years, at seven serum diltiazem concentrations ranging from 0.03 to 2.06 micrograms/ml. The percentage of unbound diltiazem ranged from 19.6 +/- 3.1 to 22.6 +/- 4.1 (mean +/- S.D.) and was independent of serum diltiazem concentration. Serum diltiazem binding was also examined in the presence of six drugs that might be used concurrently with diltiazem in patients being treated for cardiac disease. The percentage of unbound diltiazem was not influenced by digoxin, hydrochlorothiazide, phenylbutazone, propranolol, salicylic acid, or warfarin at therapeutic concentrations of these drugs over the therapeutic range of diltiazem.
4
J.J. Burns, Rose K. Rose, Theodore Chenkin et al. · Journal of Pharmacology and Experimental Therapeutics · 1953 · 251 citations
Intersubject variation of warfarin binding to protein in serum of normal subjects.
Avraham Yacobi, Stoll Rg, DiSanto Ar et al. · PubMed · 1976 · 12 citations